BRIAN BALLARD ●NEWDANIEL MCFAUL ●NEW— Legislative Director to U.S. Representative Joe Scarborough; Chief of Staff to U.S. Representatives Jeff Miller and Matt Gaetz.
IDs
Filing UUID:0a4fdb1c-a33a-4d80-8da6-b6d3e76704ff
Registrant ID:401104288
Client ID:69864
2025-11-17
SIGHTLINE ADVOCACY, LLC
AMGEN
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to the pharmaceutical industry
Registered Lobbyists (1)
TYLER STEPHENS ●NEW— Staff Assistant, Sen. Isakson; Legislative Correspondent, Sen. Chambliss; Legislative Assistant, Sen. Chambliss; Professional Staff Member, Sen. Select Committee on Intelligence; Senior Policy Advisor, Sen. Select Committee on Intelligence
IDs
Filing UUID:6987ac8d-2f31-4179-b919-7c4deec0d478
Registrant ID:401109795
Client ID:69832
2025-11-14
TSG ADVOCATES DC, LLC
BELCHER PHARMACEUTICALS LLC
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Regulatory advocacy, legislative support, and stakeholder mobilization.; Regulatory advocacy, legislative support, and stakeholder mobilization.
Registered Lobbyists (4)
BERNARD ROTHSCHILD ●NEWCHASE KROLL ●NEWCHRISTINE CALLAHAN ●NEWHALEY WEEKS ●NEW
IDs
Filing UUID:1168e87f-e6ca-4130-a52c-1f96298ccd50
Registrant ID:401109292
Client ID:69805
2025-11-12
MICHAEL BEST STRATEGIES LLC
SHARX
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues relating to healthcare access and pharmaceutical pricing, drug importation, and trade and tariffs.; Issues relating to healthcare access and pharmaceutical pricing, drug importation, and trade and tariffs.; Issues relating to healthcare access and pharmaceutical pricing, drug importation, and trade and tariffs.
Registered Lobbyists (2)
ALLISON BLANKENSHIP ●NEW— Senior Floor Advisor, Floor Assistant, Democratic Whip Katherine Clark; Floor Assistant, Speaker Nancy Pelosi; Legislative Assistant, Legislative Aide, Rep. Lucy McBath; Legislative Correspondent, Staff Assistant, Rep. Pramila JayapalNINIO FETALVO ●NEW— Dir of Strategic Communications, Deputy Dir of Communications, Centers for Medicare & Medicaid Services, U.S. Dept of Health & Human Services; Communications Advisor, Associate Advisor, Assistant Press Secretary, Executive Office of the President
IDs
Filing UUID:08a04d18-f334-4d18-85be-c107f84b53dc
Registrant ID:401103565
Client ID:69723
2025-11-11
BUCHANAN INGERSOLL & ROONEY PC
VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Issues related to compounding.
Registered Lobbyists (2)
AMANDA LINCOLN ●NEW— Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan CollinsMICHAEL STRAZZELLA ●NEW
IDs
Filing UUID:1b8fa87d-ecde-4160-9f3c-090382f5bb6a
Registrant ID:55291
Client ID:69693
2025-10-14
FEROX STRATEGIES
NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (NEMA)
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
General issues related to medical imaging and radio-pharmaceuticals.; General issues related to medical imaging and radio-pharmaceuticals.
Registered Lobbyists (5)
CRISTINA ANTELO ●NEW— Legal Fellow, Senate Democratic Steering Committee.DEBRA DIXON ●NEW— Chief of staff to Rep. Xavier Becerra, legislative director to Rep. Becerra, legislative counsel to Rep. Becerra, chief of staff, Office of Policy and Planning, U.S. Department of Education, Immigration Counsel, U.S. Department of JusticeMARK WILLIAMS ●NEW— Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson.MICHAEL TAGGART ●NEW— Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative DirectorZACHARY FRIEND ●NEW
IDs
Filing UUID:765d642a-d75f-40be-b556-0fc1d883f15d
Registrant ID:401104769
Client ID:69195
2025-10-13
OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC
POINT OF CARE MARKETING ASSOCIATION
$0
$0
Filing Details
Type: ld1 • Year: 2025 Q4
Specific Issues
Pharmaceutical communications.
Registered Lobbyists (3)
BEN DASH ●NEWERIC STEINER ●NEW— Senior Professional Staff, Senate Committee on Agriculture,Nutrition, and Forestry; Chief of Staff, Food and NutritionService, USDA; Associate Administrator for Special NutritionPrograms, Food and Nutrition Service, USDAPHILIP KARSTING ●NEW— Administrator, Foreign Agricultural Service; CoS of Sen.Herb Kohl
IDs
Filing UUID:e237070a-d08c-4008-b27a-018619cfc3c9
Registrant ID:30212
Client ID:69147
2025-10-03
WESTMORELAND160, LLC
PHLOW CORPORATION
$50,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Department of Defense Appropriations Act, 2026 (H.R.4016; S.2572) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 National Defense Authorization Act (H.R. 3838; S.2296) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction); Department of Defense Appropriations Act, 2026 (H.R.4016; S.2572) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction) Fiscal Year 2026 National Defense Authorization Act (H.R. 3838; S.2296) (Provisions related to domestic supply chain for pharmaceuticals and Military health and Threat Reduction)
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
WILLIAM RICE — Senior Policy Advisor, Rep. David Price Military Legislative Assistant, Rep. Bud Cramer Legislative Director, Rep. Henry Bonilla Military Legislative Assistant/ Appropriations Associate, Rep. Bill Young
IDs
Filing UUID:1b103edc-3d53-4482-a68e-e0a54b25219f
Registrant ID:401104802
Client ID:212204
2025-10-03
GOVERNMENT COUNSEL, LLC
HEALTHCARE DISTRIBUTION ALLIANCE
$60,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
General Issues related to drug shortages.; General issues related to pharmaceutical supply chain.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
HENRY MENN — Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
IDs
Filing UUID:10bcefab-3113-4dac-bc28-1328a8c73732
Registrant ID:401105070
Client ID:203133
2025-10-03
HORIZON GOVERNMENT AFFAIRS
CENCORA FKA AMERISOURCEBERGEN CORPORATION
$50,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician Fee Schedule Proposed Rule
Government Entities
Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Registered Lobbyists (2)
COLTON HENNINGJOEL WHITE — Former Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep Chris Shay
IDs
Filing UUID:bed24d3d-ae62-44ce-8175-58700fbdf47a
Registrant ID:315592
Client ID:185409
2025-10-03
HORIZON GOVERNMENT AFFAIRS
THE UNITED STATES PHARMACOPEIAL CONVENTION
$0
$0
Filing Details
Type: ld2 • Year: 2025 Q3
IDs
Filing UUID:50172044-baa0-4715-b717-ddad3d5b37a2
Registrant ID:315592
Client ID:66248
2025-10-03
ALAN REUTHER
UAW RETIREE MEDICAL BENEFITS TRUST
$18,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Medicaid expansion and cuts to Medicaid; Medicare changes; changes to the Affordable Care Act, including termination of enhanced subsidies; Trump's tariffs on imported drugs and Trump's MFN drug policy; extension of telehealth flexibilities; PBM transparency legislation; pharmacy anti-steering legislation; budget resolutions; budget reconciliation legislation; tax cap on employer provided health care benefits; reductions in payments to MA plans; Trumps cuts and reorganization to HHS and other health care agencies; Trump nominations to health care agencies; Medicare coverage of weight loss drugs; federal vaccine policies
DOUGLAS HUYNHKEATON HIGGINS ●NEWMICHAEL BAXTER ●NEW
IDs
Filing UUID:79c8efc5-ad55-42dd-80d5-67944a4e6193
Registrant ID:3071
Client ID:103628
2025-10-02
BAUSCH HEALTH COMPANIES
BAUSCH HEALTH COMPANIES
$0
$160,000
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Government Entities
Federal Trade Commission (FTC), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
BRIAN MUNROE
IDs
Filing UUID:783d230c-b78c-4f09-93dd-480b5d8bff67
Registrant ID:401104942
Client ID:202971
2025-10-02
HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.
TELIX PHARMACEUTICALS, INC.
$26,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
FIND Act of 2023
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (3)
ABIGAIL KAERICHERANDREW COATS — Legislative Assistant, Rep. Mark Souder.JOHN WILLIAMS — Press Secretary, House Committee on Government Reform and Oversight; Press Secretary, Rep. Dan Burton.
IDs
Filing UUID:9bd15ddc-951d-4192-baa8-b711c040b952
Registrant ID:17352
Client ID:55694
2025-10-02
GOVERNMENT COUNSEL, LLC
APOTEX CORPORATION
$20,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
HENRY MENN — Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.
IDs
Filing UUID:43b23449-47cd-45df-8578-b97b69c3d3f5
Registrant ID:401105070
Client ID:203130
2025-10-02
LOPER CONSULTING LLC
AMERICAN MEDICAL ASSOCIATION
$40,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 S. 891, Bipartisan Health Care Act; H.R. 1 One Big Beautiful Big Act; Monitoring H.R.5371 - Continuing Appropriations and Extensions Act, 2026 Equitable Community Access to Pharmacist Services Act
Government Entities
HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
GINGER LOPER — Special Assistant to the President (2002-2005)
IDs
Filing UUID:c3d266a3-3045-4390-9fd8-d12c172ea1d5
Registrant ID:400545627
Client ID:192740
2025-10-02
REVVITY, INC.
REVVITY, INC.
$0
$30,000
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Diagnostic test reimbursement and policies Genomic sequencing T-Cell Immune Response Testing Proposals related to newborn screening Newborn Screening Saves Lives Act Proposals related to pandemic preparedness FDA Medical Device Product policies H.R. 2810, Family Cord Blood Banking Act Medical Device & Pharmaceutical Adjacent Tariffs; Medical Device & Pharmaceutical Adjacent Tariff
Government Entities
Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE, Bureau of Industry and Security (BIS)
Registered Lobbyists (1)
LUIS TOVAR ●NEW
IDs
Filing UUID:cc0aade4-06d5-499a-87b9-d6e23317ea1e
Registrant ID:401105953
Client ID:208897
2025-10-01
MR. DAN CRIPPEN
AMGEN
$36,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
pharmacy rebates and discounts pharmacy R&D; pharmacy rebates and discounts; congressional procedure
Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
Government Entities
Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES
Registered Lobbyists (1)
GIL ROTH — not applicable
IDs
Filing UUID:705042af-4b1e-427a-83d1-ad7057c2900a
Registrant ID:401103605
Client ID:199773
2025-10-01
CRANE STRATEGIES
REGENERON PHARMACEUTICALS, INC.
$50,000
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Biodefense funding
Government Entities
Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
STEVEN CRANE — Staff assistant, Senator Barbara Mikulski
IDs
Filing UUID:a5edb8fb-3ed9-4522-bb48-2f17b83460d7
Registrant ID:400927689
Client ID:196249
2025-10-01
PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION
PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION
$0
$50,000
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and potential impact of tariffs on domestic biopharmaceutical manufacturing.; Discussed response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
Government Entities
Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, State, Dept of (DOS)
Registered Lobbyists (1)
GIL ROTH — not applicable
IDs
Filing UUID:7d6eb167-0413-418d-82f1-b2ba84bc9dd9
Registrant ID:401103605
Client ID:199773
2025-09-29
TAUZIN STRATEGIC NETWORKS
RAZORMETRICS
$37,500
$0
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems; Lowering Medicare & Medicaid pharmaceutical spend with advanced cost containment systems
Government Entities
Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Registered Lobbyists (1)
W.J. TAUZIN
IDs
Filing UUID:49ae1ef3-97ad-47c8-b55f-16ba088e105e
Registrant ID:400786367
Client ID:64818
2025-09-29
PARATEK PHARMACEUTICALS
PARATEK PHARMACEUTICALS
$0
$20,000
Filing Details
Type: ld2 • Year: 2025 Q3
Specific Issues
FY 26 DOD Appropriations FY 26 HHS Appropriations Biodefense Funding
Government Entities
Defense, Dept of (DOD), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE